or alternatively only certain subsets of lymphocytes are sensitive to changes in intracellular cAMP levels. , 1, 16 The fact that the CS response can be inhibited to a greater extent by indomethacin and almost completely by betamethasone lends further support to these two suggestions. These observations taken together and the fact that PDE IV inhibitors are more potent at inhibiting the latter phase of the CS response suggests that these agents are acting mainly at the level of T cells.
In conclusion, PDE IV isozymes over and above other PDE isozyme subtypes, appear to play a major role in mediating CS responses. Since these PDE IV inhibitors in general are relatively weak inhibitors of the CS response and of the mitogen-induced T-cell proliferative response, these agents are likely to have poor immunosuppressant properties. In contrast, selective PDE IV inhibitors have been shown to have potent antiinflammatory effects in models of asthma in guinea-pigs 17 and inhibit IgE synthesis from human cells. 18 Therefore, these agents are likely to have greater potential as antiasthmatic agents but without the immunosuppressive effects of corticosteroids.
